Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Triple Negative Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT07821229
What this trial is testing

Combination of Mitomycin and Carboplatin in Neoadjuvant Therapy in BRCA-associated Triple-negative Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer (Early Breast Cancer)BRCA 1 Gene MutationBRCA 2 Gene Mutation
N.N. Petrov National Medical Research Center of Oncology 30
Testing effectiveness (Phase 2)Study completedNCT04877821
What this trial is testing

The Efficacy and Safety of Sintilimab Plus Anlotinib Combined With Chemotherapy as Neoadjuvant Therapy in TNBC

Who this might be right for
Triple Negative Breast Cancer
Guangdong Provincial People's Hospital 29
Large-scale testing (Phase 3)Active Not RecruitingNCT04296175
What this trial is testing

Carboplatin Intensified Chemotherapy for TRIple NEgative Breast Cancer(CITRINE)

Who this might be right for
Triple-negative Breast Cancer
Fudan University 808
Testing effectiveness (Phase 2)Ended earlyNCT05180006
What this trial is testing

Impact of Neoadjuvant Immunotherapy in Early Stage Breast Cancer Before Standard Therapy

Who this might be right for
Breast Cancer
Gustave Roussy, Cancer Campus, Grand Paris 33
Testing effectiveness (Phase 2)Looking for participantsNCT07378306
What this trial is testing

FMD and Neoadjuvant Chemo-immunotherapy in TNBC

Who this might be right for
Breast Cancer
Sun Yat-sen University 80
Testing effectiveness (Phase 2)UnknownNCT04418154
What this trial is testing

Neoadjuvant Dose-dense EC Followed by ABX With PD-1 for Triple Negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast Cancer
Fudan University 70
Testing effectiveness (Phase 2)UnknownNCT04975451
What this trial is testing

ADCb (Anlotinib/Docetaxel/Carboplatin) as Neoadjuvant Therapy for Triple-Negative Breast Cancer

Who this might be right for
Breast Cancer
Anqin Zhang 30
Testing effectiveness (Phase 2)Ended earlyNCT01910870
What this trial is testing

Phase II Pilot Study Assessing Efficacy of a Cisplatin - Metronomic Cyclophosphamide Treatment in Patients With Metastatic Triple Negative Breast Cancer Resistant to Anthracyclines and Taxanes

Who this might be right for
Metastatic Breast Cancer
Centre Jean Perrin 4
Testing effectiveness (Phase 2)WithdrawnNCT06829199
What this trial is testing

A Clinical Study of Boserolimab (MK-5890) With Pembrolizumab and Chemotherapy in People With Early Triple-Negative Breast Cancer (MK-5890-003)

Who this might be right for
Early Triple Negative Breast Cancer
Merck Sharp & Dohme LLC
Large-scale testing (Phase 3)Study completedNCT03197935
What this trial is testing

Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer

Who this might be right for
Triple-negative Breast Cancer
Hoffmann-La Roche 333
Large-scale testing (Phase 3)Not Yet RecruitingNCT07486687
What this trial is testing

Pembrolizumab Adjuvant in Patients With Early-stage Triple Negative Breast Cancer With Residual Disease After Neoadjuvant Pembrolizumab Plus Chemotherapy

Who this might be right for
Triple Negative Breast Cancer (TNBC), Early SettingEarly Stage Triple-Negative Breast CarcinomaTriple -Negative Breast Cancer+2 more
The Netherlands Cancer Institute 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT07768436
What this trial is testing

Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer

Who this might be right for
Adenocarcinoma of the BreastBreast CancerTriple Negative Breast Cancer
Memorial Sloan Kettering Cancer Center 76
Testing effectiveness (Phase 2)Study completedNCT03243838
What this trial is testing

Low-dose Apatinib Combined With Neoadjuvant Chemotherapy in the Treatment of Early Triple Negative Breast Cancer

Who this might be right for
Triple-Negative Breast Cancer
Guangdong Provincial People's Hospital 31
Testing effectiveness (Phase 2)Looking for participantsNCT06831955
What this trial is testing

LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer (TNBC), Early Setting
Universitaire Ziekenhuizen KU Leuven 356
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07007780
What this trial is testing

Sacituzumab Tirumotecan in Neoadjuvant Treatment of Early-Stage TNBC

Who this might be right for
Triple -Negative Breast Cancer
Xijing Hospital 35
Testing effectiveness (Phase 2)WithdrawnNCT06710197
What this trial is testing

IL-1 Inhibition in Early TNBC

Who this might be right for
Early Stage Triple Negative ER Low Breast Cancer
University Health Network, Toronto
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07107217
What this trial is testing

Camrelizumab in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-negative Breast Cancer

Who this might be right for
Breast Cancer
Blokhin's Russian Cancer Research Center 40
Not applicableLooking for participantsNCT04959474
What this trial is testing

Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage 1 Breast Cancer AJCC v8Anatomic Stage 2 Breast Cancer AJCC v8+4 more
Thomas Jefferson University 80
Testing effectiveness (Phase 2)Study completedNCT05112536
What this trial is testing

Trilaciclib, a CDK4/6 Inhibitor, in Patients With Early-Stage Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast CancerBreast Cancer
G1 Therapeutics, Inc. 24
Not applicableStudy completedNCT02850302
What this trial is testing

Triple Negative Breast Cancer: Identification Pilot Study of Predictive Transcriptome Profiles of Early Tumor Drug Resistance Observed in 18F-Fluorodeoxyglucose (FDG) PET

Who this might be right for
Breast Neoplasms
Centre Georges Francois Leclerc 23
Next Page